Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial

File Description SizeFormat 
FOURIER Design Paper 11-24-15 clean.docxAccepted version211.54 kBMicrosoft WordDownload
Title: Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Author(s): Sabatine, MS
Giugliano, RP
Keech, A
Honarpour, N
Wang, H
Liu, T
Wasserman, SM
Scott, R
Sever, PS
Pedersen, TR
Item Type: Journal Article
Publication Date: 1-Mar-2016
Date of Acceptance: 25-Nov-2015
URI: http://hdl.handle.net/10044/1/30169
DOI: https://dx.doi.org/10.1016/j.ahj.2015.11.015
ISSN: 1097-6744
Publisher: Elsevier
Start Page: 94
End Page: 101
Journal / Book Title: American Heart Journal
Volume: 173
Copyright Statement: © 2015 Elsevier Inc. All rights reserved. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
CORONARY-HEART-DISEASE
PLACEBO-CONTROLLED TRIAL
LOW-DENSITY-LIPOPROTEIN
PRIMARY-PREVENTION TRIAL
EVOLOCUMAB AMG 145
STATIN THERAPY
LDL-C
FAMILIAL HYPERCHOLESTEROLEMIA
MYOCARDIAL-INFARCTION
MONOCLONAL-ANTIBODY
Cardiovascular System & Hematology
1102 Cardiovascular Medicine And Haematology
1117 Public Health And Health Services
Publication Status: Published
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons